Company intelligence / Profile preview

Asterix Foods

Ness Ziona, Central, Israelasterixfoods.com ↗

Ownership: Private
Employees: ~2
Development stage: Preclinical

Overview

Asterix Foods develops fully functional animal-free glycoproteins using plant cell culture technology. Their approach enables precise glycosylation patterns that are difficult to achieve with microbial fermentation, allowing their proteins to serve as drop-in replacements in existing foods without compromising taste, texture, price, or nutrition. The company's goal is to create sustainable and scalable alternatives to animal-derived ingredients for the global food industry.

Modalities: ProteinGlycoprotein
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Asterix Foods.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asterix Foods.

Explore the full profile